Cargando…
Long noncoding RNA-mediated activation of androgen receptor in prostate cancer
Remarkable progress has been made in molecular characterization of prostate cancer (PCa) with continued innovations in high throughput technologies evaluating human cancer.123 Since the completion of the Human Genome Project it has been estimated that only about 1.5%–2% of our genome codes for prote...
Autores principales: | Petrovics, Gyorgy, Srivastava, Shiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023370/ https://www.ncbi.nlm.nih.gov/pubmed/24713835 http://dx.doi.org/10.4103/1008-682X.126398 |
Ejemplares similares
-
Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo
por: Pestell, Richard G, et al.
Publicado: (2014) -
Androgen receptor functions in prostate cancer development and progression
por: Balk, Steven P
Publicado: (2014) -
Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2015) -
Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2019) -
Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation
por: Lai, John, et al.
Publicado: (2014)